| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 6,430 | 5,480 | 6,570 | 18,520 | 15,290 |
| Sales Growth | +17.34% | -16.59% | -64.52% | +21.12% | +114.15% |
| Net Income | -22,030 | -21,920 | -42,530 | -49,980 | -36,960 |
| Net Income Growth | -0.50% | +48.46% | +14.91% | -35.23% | -83.79% |
Viveve Medical Inc (VIVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Viveve Medical, Inc. is a medical device company focused on technologies for the cardiac and vascular markets. The Company's lead product, RenalGuard (R), is designed to remove contrast dyes that are known to be toxic to the kidneys. Viveve Medical Inc., formerly known as PLC Systems Inc., is headquartered in Milford, Massachusetts.
Fiscal Year End Date: 12/31